Search
for
Sort by
Research 451–480 of 1000+
- Markers of inflammation, metabolic disorders, and principles of treatment for alopecia areata in children
- The role of leptin in selected skin diseases
- Alopecia Areata Associated with Dupilumab: National Database Study
- Dupilumab Associated Progression of Alopecia Areata to Alopecia Universalis: A Case Report
- A case of dupilumab-induced psoriatic alopecia
- Alopecia Areata Associated with Dupilumab: A Case Report and Literature Review
- In This Issue
- The vitamin B5/coenzyme A axis: A target for immunomodulation?
- A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- When the skin meets the bowel: About a case
- Penilaian Teknis dan Ekonomi Unit Penangkapan Jaring Cumi di PPP Bajomulyo Pati, Jawa Tengah.
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- Dupilumab in a 9-week-old with Netherton Syndrome Leads to Deep Symptom Control
- Development of squamous cell carcinoma from erythroplasia of Queyrat following photodynamic therapy
- Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata
- THE USE OF TOFACITINIB IN THE TREATMENT OF IMMUNE-MEDIATED UNIVERSAL ALOPECIA IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT
- Acne-Associated Syndromes
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- Granulomatous pigmented purpuric dermatosis containing Propionibacterium acnes
- The great atopic diseases epidemic: does chemical exposure play a role?
- Challenging Regional Psoriasis and Ustekinumab Biotherapy: Impact of the Patterns of Disease
- Oxidative stress and alopecia areata
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis
- The role of janus kinases in the treatment of autoimmune skin diseases
- 272 Structural changes in human skin after topical application of glucocorticoids assessed by in vivo imaging technologies
- Upadacitinib is effective in treating psoriasis combined with lichen planus: a case report
- Evaluation of Serum Toll-Like Receptor 4, Interferon Gamma, and Interleukin-17 Levels in Iraqi Patients with Alopecia Areata
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control